The application of biomarkers in clinical trials for motor neuron disease
about
Therapeutic neuroprotective agents for amyotrophic lateral sclerosisPlasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALSCombination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.Comparative Analysis of VOCs in Exhaled Breath of Amyotrophic Lateral Sclerosis and Cervical Spondylotic Myelopathy PatientsBioinformatic-driven search for metabolic biomarkers in diseaseHow can we improve clinical trials in amyotrophic lateral sclerosis?Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).Metabolomics in amyotrophic lateral sclerosis: how far can it take us?Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Further development of biomarkers in amyotrophic lateral sclerosis.Reduced Interhemispheric Functional Connectivity in the Motor Cortex during Rest in Limb-Onset Amyotrophic Lateral Sclerosis.Blood volatile organic compounds as potential biomarkers for amyotrophic lateral sclerosis: an animal study in the SOD1 G93A mouse.Amyotrophic Lateral Sclerosis: An Aging-Related Disease
P2860
Q27015029-E3BA308C-FF29-4E8B-B7D3-21DD76552A05Q28481340-CB6D2197-53F4-4B4B-83A1-F7BDB9625A57Q34792280-86746F7A-26C4-4B91-940B-84A9A8F27B42Q35686186-288AFFD6-FBB0-42CA-B495-E85FDA204F1CQ36925672-4B7C2F5C-3A1D-4F69-AD5B-E18C0E060477Q37925151-715A64BF-96EA-449F-857B-CB86A522D311Q37938694-8FD43F77-9A97-44F5-A98E-F10F9992C0FBQ38058054-4A5B0118-C944-4D33-BCB3-FA4A515C19FFQ38232360-A2FE7D42-F8AD-4A15-AD00-A72391DD77BBQ38715322-C22BB307-1F82-44D1-B175-B9F8D2FC9533Q38847200-43CEB1E8-7E2F-45C7-93B8-F4121B7B4140Q38856405-4C090BD0-4745-424F-B3F8-EBFE6FFC5CC4Q42160391-EDAC69E9-00FF-44CE-8635-12B6D2BCCE50Q45234238-A2EA20B3-D37B-4263-A91A-C4D1E583FE84Q56839346-F25B2EC7-2CBE-4F12-A174-11241197DE7D
P2860
The application of biomarkers in clinical trials for motor neuron disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The application of biomarkers in clinical trials for motor neuron disease
@ast
The application of biomarkers in clinical trials for motor neuron disease
@en
type
label
The application of biomarkers in clinical trials for motor neuron disease
@ast
The application of biomarkers in clinical trials for motor neuron disease
@en
prefLabel
The application of biomarkers in clinical trials for motor neuron disease
@ast
The application of biomarkers in clinical trials for motor neuron disease
@en
P2860
P356
P1476
The application of biomarkers in clinical trials for motor neuron disease
@en
P2093
Jeban Ganesalingam
Robert Bowser
P2860
P304
P356
10.2217/BMM.09.71
P577
2010-04-01T00:00:00Z